{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:45:53Z","timestamp":1794966353673,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Periodontal regenerative surgery is a well-established treatment modality for intrabony periodontal defects. Enamel matrix derivative (EMD) is one of the most extensively documented biologic agents, whereas platelet-rich fibrin (PRF) has emerged as a promising autologous alternative. This prospective randomized controlled clinical study aimed to compare the long-term clinical outcomes of PRF and EMD in the treatment of periodontal intrabony defects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty patients with periodontitis Stage III\/IV, grade B\/C and at least one intrabony defect [probing pocket depth (PPD)\u2009\u2265\u20096\u00a0mm; intrabony component\u2009\u2265\u20094\u00a0mm] were randomly assigned to surgery using PRF (test group) or EMD (control group). The primary outcome was clinical attachment level (CAL) gain. Secondary outcomes included PPD reduction, gingival recession (GR), and bone sounding (BS) changes. Clinical parameters were recorded at baseline, 6 months, and 3 years postoperatively. Intergroup comparisons of mean clinical changes were performed using appropriate parametric and nonparametric statistical tests (\u03b1\u2009=\u20090.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-six patients completed the 3-year follow-up. Both treatment modalities resulted in significant clinical improvements that remained stable over time. At 6 months, mean PPD reduction was 4.40\u2009\u00b1\u20092.44\u00a0mm in the PRF group and 3.53\u2009\u00b1\u20092.67\u00a0mm in the EMD group, while mean CAL gain measured 3.87\u2009\u00b1\u20092.20\u00a0mm and 2.13\u2009\u00b1\u20092.80\u00a0mm, respectively. GR increase was lower in the PRF group compared with the EMD group (0.53\u2009\u00b1\u20091.13\u00a0mm vs. 1.40\u2009\u00b1\u20091.45\u00a0mm), although the difference did not reach statistical significance (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.079). At 3 years, mean PPD reduction was 3.69\u2009\u00b1\u20091.70\u00a0mm in the PRF group and 3.31\u2009\u00b1\u20093.45\u00a0mm in the EMD group, while CAL gain measured 3.77\u2009\u00b1\u20091.48\u00a0mm and 2.54\u2009\u00b1\u20093.62\u00a0mm, respectively. A significantly lower increase in GR was observed in the PRF group compared with the EMD group at 3 years (\u2212\u20090.08\u2009\u00b1\u20090.64\u00a0mm vs. 0.77\u2009\u00b1\u20091.30\u00a0mm;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.046). No statistically significant intergroup differences were detected for PPD reduction, CAL gain, or BS reduction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PRF and EMD provided comparable and stable long-term clinical improvements following regenerative periodontal surgery of intrabony defects. PRF may represent a reliable autologous alternative to EMD in periodontal regenerative therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov registration number NCT07183631 retrospectively registered, 14\/09\/2025.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12903-026-08845-y","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:03:19Z","timestamp":1781528599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Three-year results of a prospective, controlled clinical study evaluating treatment of intra-bony defects with PRF or EMD- a randomized control trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Ferenc","family":"D\u0151ri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florina","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Arweiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Solyom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"4","key":"8845_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1034\/j.1600-051X.2002.290407.x","volume":"29","author":"MS Tonetti","year":"2002","unstructured":"Tonetti MS, Lang NP, Cortellini P, Suvan JE, Adriaens P, Dubravec D, Fonzar A, Fourmousis I, Mayfield L, Rossi R, et al. Enamel matrix proteins in the regenerative therapy of deep intrabony defects. J Clin Periodontol. 2002;29(4):317\u201325.","journal-title":"J Clin Periodontol"},{"issue":"7","key":"8845_CR2","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00784-015-1491-7","volume":"19","author":"M Matarasso","year":"2015","unstructured":"Matarasso M, Iorio-Siciliano V, Blasi A, Ramaglia L, Salvi GE, Sculean A. Enamel matrix derivative and bone grafts for periodontal regeneration of intrabony defects. A systematic review and meta-analysis. Clin Oral Investig. 2015;19(7):1581\u201393.","journal-title":"Clin Oral Investig"},{"issue":"4","key":"8845_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.11607\/prd.4148","volume":"39","author":"V Iorio-Siciliano","year":"2019","unstructured":"Iorio-Siciliano V, Blasi A, Nuzzolo P, Matarasso M, Isola G, Ramaglia L. Treatment of Periodontal Intrabony Defects Using Enamel Matrix Derivative: Surgical Reentry After an Observation Period of at Least 5 Years. Int J Periodontics Restor Dent. 2019;39(4):537\u201343.","journal-title":"Int J Periodontics Restor Dent"},{"key":"8845_CR4","first-page":"257","volume":"22","author":"OC Vela","year":"2024","unstructured":"Vela OC, Boariu M, Rusu D, Iorio-Siciliano V, Sculean A, Stratul SI. Clinical and Radiographic Evaluation of Intrabony Periodontal Defects Treated with Hyaluronic Acid or Enamel Matrix Proteins: A 6-Month Prospective Study. Oral Health Prev Dent. 2024;22:257\u201370.","journal-title":"Oral Health Prev Dent"},{"issue":"2","key":"8845_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1902\/jop.2001.72.2.190","volume":"72","author":"A Sculean","year":"2001","unstructured":"Sculean A, Blaes A, Arweiler N, Reich E, Donos N, Brecx M. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins. J Periodontol. 2001;72(2):190\u20135.","journal-title":"J Periodontol"},{"issue":"4","key":"8845_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1902\/jop.2002.73.4.401","volume":"73","author":"A Sculean","year":"2002","unstructured":"Sculean A, Barb\u00e9 G, Chiantella GC, Arweiler NB, Berakdar M, Brecx M. Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. J Periodontol. 2002;73(4):401\u20138.","journal-title":"J Periodontol"},{"issue":"4","key":"8845_CR7","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s10266-024-00949-7","volume":"112","author":"L Silva FFVe, Chauca-Baja\u00f1a","year":"2024","unstructured":"Silva FFVe, Chauca-Baja\u00f1a L, Caponio VCA, Cueva KAS, Velasquez-Ron B, Pad\u00edn-Iruegas ME, Almeida LL, Lorenzo-Pouso AI, Su\u00e1rez-Pe\u00f1aranda JM, P\u00e9rez-Say\u00e1ns M. Regeneration of periodontal intrabony defects using platelet-rich fibrin (PRF): a systematic review and network meta-analysis. Odontology. 2024;112(4):1047\u201368.","journal-title":"Odontology"},{"issue":"3","key":"8845_CR8","first-page":"e56","volume":"101","author":"J Choukroun","year":"2006","unstructured":"Choukroun J, Diss A, Simonpieri A, Girard M-O, Schoeffler C, Dohan SL, Dohan AJJ, Mouhyi J, Dohan DM. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part IV: Clinical effects on tissue healing. Oral Surgery, Oral Medicine, Oral Pathology. Oral Radiol Endodontics. 2006;101(3):e56\u201360.","journal-title":"Oral Radiol Endodontics"},{"issue":"7","key":"8845_CR9","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.2174\/138920112800624382","volume":"13","author":"DM Dohan Ehrenfest","year":"2012","unstructured":"Dohan Ehrenfest DM, Bielecki T, Jimbo R, Barb\u00e9 G, Del Corso M, Inchingolo F, Sammartino G. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol. 2012;13(7):1145\u201352.","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"8845_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1902\/jop.2016.160443","volume":"88","author":"M Fujioka-Kobayashi","year":"2017","unstructured":"Fujioka-Kobayashi M, Miron RJ, Hernandez M, Kandalam U, Zhang Y, Choukroun J. Optimized Platelet-Rich Fibrin With the Low-Speed Concept: Growth Factor Release, Biocompatibility, and Cellular Response. J Periodontol. 2017;88(1):112\u201321.","journal-title":"J Periodontol"},{"issue":"9","key":"8845_CR11","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1007\/s00784-016-1719-1","volume":"20","author":"E Kobayashi","year":"2016","unstructured":"Kobayashi E, Fl\u00fcckiger L, Fujioka-Kobayashi M, Sawada K, Sculean A, Schaller B, Miron RJ. Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Invest. 2016;20(9):2353\u201360.","journal-title":"Clin Oral Invest"},{"issue":"12","key":"8845_CR12","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1902\/jop.2011.110075","volume":"82","author":"A Sharma","year":"2011","unstructured":"Sharma A, Pradeep AR. Treatment of 3-wall intrabony defects in patients with chronic periodontitis with autologous platelet-rich fibrin: a randomized controlled clinical trial. J Periodontol. 2011;82(12):1705\u201312.","journal-title":"J Periodontol"},{"issue":"4","key":"8845_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4103\/jnsm.jnsm_2_24","volume":"7","author":"P Zuleika","year":"2024","unstructured":"Zuleika P, Saleh I, Murti K, Liberty IA, Legiran, Irfanuddin, Surono A. Platelet-rich Fibrin: A Systematic Review of Its Action. J Nat Sci Med. 2024;7(4):242\u201352.","journal-title":"J Nat Sci Med"},{"issue":"1\u20132","key":"8845_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000454919","volume":"58","author":"H Sorg","year":"2017","unstructured":"Sorg H, Tilkorn DJ, Hager S, Hauser J, Mirastschijski U. Skin Wound Healing: An Update on the Current Knowledge and Concepts. Eur Surg Res. 2017;58(1\u20132):81\u201394.","journal-title":"Eur Surg Res"},{"issue":"1","key":"8845_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/ten.teb.2016.0233","volume":"23","author":"RJ Miron","year":"2017","unstructured":"Miron RJ, Fujioka-Kobayashi M, Bishara M, Zhang Y, Hernandez M, Choukroun J. Platelet-Rich Fibrin and Soft Tissue Wound Healing: A Systematic Review. Tissue Eng Part B Rev. 2017;23(1):83\u201399.","journal-title":"Tissue Eng Part B Rev"},{"issue":"1","key":"8845_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40729-022-00440-4","volume":"8","author":"L Baca-Gonzalez","year":"2022","unstructured":"Baca-Gonzalez L, Serrano Zamora R, Rancan L, Gonz\u00e1lez Fern\u00e1ndez-Tresguerres F, Fern\u00e1ndez-Tresguerres I, L\u00f3pez-Pintor RM, L\u00f3pez-Quiles J, Leco I, Torres J. Plasma rich in growth factors (PRGF) and leukocyte-platelet rich fibrin (L-PRF): comparative release of growth factors and biological effect on osteoblasts. Int J Implant Dentistry. 2022;8(1):39.","journal-title":"Int J Implant Dentistry"},{"key":"8845_CR17","first-page":"638043","volume":"2013","author":"Q Li","year":"2013","unstructured":"Li Q, Pan S, Dangaria SJ, Gopinathan G, Kolokythas A, Chu S, Geng Y, Zhou Y, Luan X. Platelet-rich fibrin promotes periodontal regeneration and enhances alveolar bone augmentation. Biomed Res Int. 2013;2013:638043.","journal-title":"Biomed Res Int"},{"issue":"4","key":"8845_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1834-7819.2011.01362.x","volume":"56","author":"YC Chang","year":"2011","unstructured":"Chang YC, Zhao JH. Effects of platelet-rich fibrin on human periodontal ligament fibroblasts and application for periodontal infrabony defects. Aust Dent J. 2011;56(4):365\u201371.","journal-title":"Aust Dent J"},{"key":"8845_CR19","doi-asserted-by":"publisher","first-page":"e081123","DOI":"10.1136\/bmj-2024-081123","volume":"389","author":"S Hopewell","year":"2025","unstructured":"Hopewell S, Chan AW, Collins GS, Hr\u00f3bjartsson A, Moher D, Schulz KF, Tunn R, Aggarwal R, Berkwits M, Berlin JA, et al. CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ. 2025;389:e081123.","journal-title":"BMJ"},{"issue":"20","key":"8845_CR20","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association Declaration","year":"2013","unstructured":"World Medical Association Declaration. of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134.","journal-title":"JAMA"},{"issue":"6","key":"8845_CR21","doi-asserted-by":"publisher","first-page":"Suppl","DOI":"10.1902\/jop.1967.38.6.610","volume":"38","author":"H L\u00f6e","year":"1967","unstructured":"L\u00f6e H. The Gingival Index, the Plaque Index and the Retention Index Systems. J Periodontol. 1967;38(6):Suppl.","journal-title":"J Periodontol"},{"issue":"11","key":"8845_CR22","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/jcpe.12598","volume":"43","author":"H Aydemir Turkal","year":"2016","unstructured":"Aydemir Turkal H, Demirer S, Dolgun A, Keceli HG. Evaluation of the adjunctive effect of platelet-rich fibrin to enamel matrix derivative in the treatment of intrabony defects. Six-month results of a randomized, split-mouth, controlled clinical study. J Clin Periodontol. 2016;43(11):955\u201364.","journal-title":"J Clin Periodontol"},{"issue":"1","key":"8845_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/jcpe.12643","volume":"44","author":"AB Castro","year":"2017","unstructured":"Castro AB, Meschi N, Temmerman A, Pinto N, Lambrechts P, Teughels W, Quirynen M. Regenerative potential of leucocyte- and platelet-rich fibrin. Part A: intra-bony defects, furcation defects and periodontal plastic surgery. A systematic review and meta-analysis. J Clin Periodontol. 2017;44(1):67\u201382.","journal-title":"J Clin Periodontol"},{"issue":"Suppl 3","key":"8845_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1034\/j.1600-051X.29.s3.7.x","volume":"29","author":"L Trombelli","year":"2002","unstructured":"Trombelli L, Heitz-Mayfield LJ, Needleman I, Moles D, Scabbia A. A systematic review of graft materials and biological agents for periodontal intraosseous defects. J Clin Periodontol. 2002;29(Suppl 3):117\u201335. discussion 160\u2009\u2013\u2009112.","journal-title":"J Clin Periodontol"},{"issue":"s8","key":"8845_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-051X.2008.01264.x","volume":"35","author":"DD Bosshardt","year":"2008","unstructured":"Bosshardt DD. Biological mediators and periodontal regeneration: a review of enamel matrix proteins at the cellular and molecular levels. J Clin Periodontol. 2008;35(s8):87\u2013105.","journal-title":"J Clin Periodontol"},{"issue":"5","key":"8845_CR26","first-page":"220","volume":"100","author":"A Sculean","year":"2007","unstructured":"Sculean A, Windisch P, D\u00f6ri F, Keglevich T, Moln\u00e1r B, Gera I. Emdogain in regenerative periodontal therapy. A review of the literature. Fogorv Sz. 2007;100(5):220\u201332.","journal-title":"Fogorv Sz"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-026-08845-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:04:57Z","timestamp":1787569497000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-026-08845-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8845"],"URL":"https:\/\/doi.org\/10.1186\/s12903-026-08845-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9163030\/v1","asserted-by":"object"}]},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethics committee at Semmelweis University, Budapest, Hungary (SE RKEB: 116\/2021). The study was conducted following the Helsinki Declaration. Informed consent to participate was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1537"}}